178372-19-5

Basic information

• Product Name: 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol
• Synonyms: 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol;2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethan-1-ol
• CAS NO: 178372-19-5
• Molecular Formula: C11H16N2O
• Molecular Weight: 192.26
• Mol File: 178372-19-5.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 353.2 °C at 760 mmHg
• Flash Point: 167.4 °C
• Appearance: /
• Density: 1.094 g/cm³
• Vapor Pressure: 1.34E-05mmHg at 25°C
• Refractive Index: 1.539
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol(178372-19-5)
• EPA Substance Registry System: 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol(178372-19-5)

Safety Data

• Hazardous Substances Data: 178372-19-5(Hazardous Substances Data)

Usage

General Description

2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol is a chemical compound with a complex molecular structure. It contains a pyrrolidine ring and a pyridine ring, both of which are attached to a central ethyl alcohol group. 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol may have potential applications in the pharmaceutical or chemical industries due to its unique structure and potential biological activity. However, further research and testing would be necessary to fully understand its properties and potential uses.

InChI:InChI=1/C11H16N2O/c14-8-5-11(4-7-12-9-11)10-3-1-2-6-13-10/h1-3,6,12,14H,4-5,7-9H2

Upstream product

• 178372-18-4 3-(pyridin-2-yl)-5-oxo-pyrrolidin-3-yl-acetic acid ethyl ester 

Relevant articles and documents

SUBSTITUTED 4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPANES USEFUL FOR THE TREATMENT ALLERGIC DISEASES

The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4] diazepane derivatives of formula (1): and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.

Substituted piperidines useful for the treatment of allergic diseases

The present invention relates to novel substituted piperidine derivatives of the formula STR1stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic diseases including: seasonal rhinitis, allergic rhinitis, and sinusitis.

Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease

The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4]diazepane derivatives of formula (1): and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.